Oral semaglutide requires strict fasting conditions due to its low bioavailability, whereas orforglipron can be taken at any time of day without food or water restrictions
2 These studies, including the SUSTAIN clinical trial program, demonstrated both safety and effectiveness for treating type 2 diabetes
Semaglutide belongs to a class of drugs known as GLP-1 receptor agonists as they resemble a hormone called glucagon-like peptide 1, which stimulates insulin production, helps to lower blood sugar levels and, due to those metabolic effects, often results in weight loss
Acute illness may require temporary dose adjustment or suspension of GLP-1 therapy, particularly if you cannot maintain adequate fluid intake
This is mainly due to the strong acceptance of diabetes and obesity management
When used in research, melanotan 2 is being investigated in its potential role in stimulating melanogenesis